ArticleInternal medicine (Tokyo, Japan)2026

Two-year Outcomes of Remission Induction Therapy with Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis: A Case Series.

Satoshi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.